Tags

Type your tag names separated by a space and hit enter

The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis.
Rheumatol Int. 2013 Aug; 33(8):1991-9.RI

Abstract

The aim of this study was to determine whether the protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T polymorphism confers susceptibility to rheumatoid arthritis (RA) in populations with different ethnicities. MEDLINE database and manual search were utilized to identify articles in which the PTPN22 polymorphism was determined in RA patients and controls. A meta-analysis was conducted on the associations between the PTPN22 C1858T polymorphism and RA using (1) allelic contrast and (2) dominant model. A total of 30 separate comparisons involving 17,961 RA patients and 18,611 controls were considered in this meta-analysis. Meta-analysis showed an association between the T allele and RA in all subjects (OR = 1.490, 95% CI = 1.332-1.668, P < 1.0 × 10(-9)). After stratification by ethnicity, analysis indicated that the T allele was significantly associated with RA in Europeans and in Non-Europeans (OR = 1.423, 95% CI = 1.260-1.605, P = 1.0 × 10(-8); OR = 1.902, 95% CI = 1.488-2.430, P = 2.8 × 10(-8)). Meta-analysis of the CT + TT genotype showed the same result patterns as that shown by the PTPN22 C1858T polymorphism T allele. Furthermore, a direct comparison between rheumatoid factor (RF)-positive and RF-negative subjects revealed a significant association with the T allele in RA patients with RF, but not in subjects without RF (OR = 1.561, 95% CI = 1.373-1.775, P < 1.0 × 10(-9)). This meta-analysis confirms that the PTPN22 C1858T polymorphism is associated with RA susceptibility in different ethnic groups, especially in Europeans, and the PTPN22 C1858T polymorphism T allele is significantly more prevalent in RF-positive patents than in RF-negative patients.

Authors+Show Affiliations

Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 126-1 ga, Anam-dong 5-ga, Seongbuk-gu, Seoul 136-705, Korea.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23370857

Citation

Song, Gwan Gyu, et al. "The PTPN22 C1858T Polymorphism and Rheumatoid Arthritis: a Meta-analysis." Rheumatology International, vol. 33, no. 8, 2013, pp. 1991-9.
Song GG, Bae SC, Kim JH, et al. The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2013;33(8):1991-9.
Song, G. G., Bae, S. C., Kim, J. H., & Lee, Y. H. (2013). The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatology International, 33(8), 1991-9. https://doi.org/10.1007/s00296-013-2679-2
Song GG, et al. The PTPN22 C1858T Polymorphism and Rheumatoid Arthritis: a Meta-analysis. Rheumatol Int. 2013;33(8):1991-9. PubMed PMID: 23370857.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis. AU - Song,Gwan Gyu, AU - Bae,Sang-Cheol, AU - Kim,Jae-Hoon, AU - Lee,Young Ho, Y1 - 2013/01/31/ PY - 2010/02/25/received PY - 2013/01/19/accepted PY - 2013/2/2/entrez PY - 2013/2/2/pubmed PY - 2014/3/7/medline SP - 1991 EP - 9 JF - Rheumatology international JO - Rheumatol. Int. VL - 33 IS - 8 N2 - The aim of this study was to determine whether the protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T polymorphism confers susceptibility to rheumatoid arthritis (RA) in populations with different ethnicities. MEDLINE database and manual search were utilized to identify articles in which the PTPN22 polymorphism was determined in RA patients and controls. A meta-analysis was conducted on the associations between the PTPN22 C1858T polymorphism and RA using (1) allelic contrast and (2) dominant model. A total of 30 separate comparisons involving 17,961 RA patients and 18,611 controls were considered in this meta-analysis. Meta-analysis showed an association between the T allele and RA in all subjects (OR = 1.490, 95% CI = 1.332-1.668, P < 1.0 × 10(-9)). After stratification by ethnicity, analysis indicated that the T allele was significantly associated with RA in Europeans and in Non-Europeans (OR = 1.423, 95% CI = 1.260-1.605, P = 1.0 × 10(-8); OR = 1.902, 95% CI = 1.488-2.430, P = 2.8 × 10(-8)). Meta-analysis of the CT + TT genotype showed the same result patterns as that shown by the PTPN22 C1858T polymorphism T allele. Furthermore, a direct comparison between rheumatoid factor (RF)-positive and RF-negative subjects revealed a significant association with the T allele in RA patients with RF, but not in subjects without RF (OR = 1.561, 95% CI = 1.373-1.775, P < 1.0 × 10(-9)). This meta-analysis confirms that the PTPN22 C1858T polymorphism is associated with RA susceptibility in different ethnic groups, especially in Europeans, and the PTPN22 C1858T polymorphism T allele is significantly more prevalent in RF-positive patents than in RF-negative patients. SN - 1437-160X UR - https://www.unboundmedicine.com/medline/citation/23370857/The_PTPN22_C1858T_polymorphism_and_rheumatoid_arthritis:_a_meta_analysis_ L2 - https://dx.doi.org/10.1007/s00296-013-2679-2 DB - PRIME DP - Unbound Medicine ER -